Mappa tal-evidenza
Altitudni: kif tidher l-evidenza
12 pubblikazzjonijiet, 0 minnhom trials u 8 sintesi. Din il-paġna tiddeskrivi l-forma ta' dik il-letteratura aktar milli tikkonkludiha.
X'jikkostitwixxi din il-letteratura
Is-sintesi hija 'l quddiem mill-letteratura primarja hawn — reviżjonijiet u meta-analiżi li jdraw fuq numru modest ta' studji bażiċi. Ittieħed konklużjonijiet b'fiduċja bil-kawtela li l-għadd tal-kampjonu jixraqlu.
L-iskop li jimporta l-aktar huwa bejn is-sintesi u r-riċerka primarja. Meta-analiżi tikkonsolida t-trials u hija l-aktar ħaġa viċin ta' tweġiba stabbilita li l-qasam jipproduċi. Reviżjoni narrattiva hija qari ta' grupp wieħed tal-istess materjal u tista' tkun selettiva mingħajr ma tkun diżonesta. L-għadd tagħhom flimkien, li ħafna mill-għadd ta' ċitazzjonijiet jagħmlu, jiskopri eżattament il-ħaġa li trid tkun taf.
Kif hi mibnija din il-paġna
Kollox hawn fuq huwa kkalkulat mill-ċitazzjonijiet li dan is-sit ħa minn PubMed u Crossref, mhux miktub bil-hand. Meta l-ħsad settimanali jsib paper ġdid dwar dan is-suġġett, dawn il-għaddijiet jinbidlu u l-karatterizzazzjoni tinbidel magħhom. Dak huwa l-punt: dikjarazzjoni miktuba bil-hand dwar kemm hija b'saħħitha l-bażi ta' evidenza tibda tiżdied il-ġurnata li tkun miktuba.
It-tip ta' pubblikazzjoni huwa meħud kif ir-rekords tas-sors jindika. Dan mhuwiex perfett — il-ġurnali jlabeljaw b'mod inkonsistenti, u paper indikata bħala "reviżjoni" tista' tkun waħda sistematika — għalhekk it-trattament tal-bandi bħala approssimattivi. Huma biżżejjed preċiżi biex jiddistingwu letteratura ta' trial minn letteratura ta' kumment, li huwa l-iskop li jimporta.
L-aktar xogħol b'saħħtu dwar dan is-suġġett
Ordnat skont id-disinn tal-istudju l-ewwel, imbagħad ir-riċentezza. Is-sett sħiħ huwa elenkat fir-referenzi hawn taħt.
- Effetti komparattivi ta' interventi farmaċewtiċi għall-prevenzjoni ta' mard tal-muntanji akuti: Reviżjoni sistematika u meta-analiżi tan-netwerk Bayesian — Wang J, Lian N, Tang K et al., 2025, meta-analiżi
- Effett ta' supplimentazzjoni ta' nitrati fuq il-livelli ta' saturazzjoni tal-ossiġenu għall-prevenzjoni ta' mard tal-muntanji akuti: Reviżjoni sistematika u meta-analiżi — Nafi'an MRT, Sabirin RM, Wibowo RA et al., 2024, meta-analiżi
- Ibuprofen kontra acetazolamide għall-prevenzjoni ta' mard tal-muntanji akuti — Schilling M, Irarrázaval S, 2020, meta-analiżi
- Acetazolamide għall-kura ta' mard tal-muntanji akuti — Tapia L, Irarrázaval S, 2019, meta-analiżi
- Estratt ta' Ginkgo biloba għall-prevenzjoni ta' mard tal-muntanji akuti: reviżjoni sistematika u meta-analiżi ta' triali kontrollati randomizzati — Tsai TY, Wang SH, Lee YK et al., 2018, meta-analiżi
- Dexamethasone għall-prevenzjoni ta' mard tal-muntanji akuti: reviżjoni sistematika u meta-analiżi — Tang E, Chen Y, Luo Y, 2014, meta-analiżi
- Acetazolamide għall-prevenzjoni ta' mard tal-muntanji akuti — reviżjoni sistematika u meta-analiżi — Ritchie ND, Baggott AV, Andrew Todd WT, 2012, meta-analiżi
- Mard tal-altitudni — Murdoch D, 2010, reviżjoni sistematika
- Altitudni Għolja — Berger MM, Luks AM, 2023, reviżjoni
- Mard tal-altitudni għolja akuta — Luks AM, Swenson ER, Bärtsch P, 2017, reviżjoni
Kemm hemm riċerka dwar l-altitudni?
Iżda riċerka aktar ħafna tfisser konklużjoni iktar b'saħħitha?
Kemm hi attwali din?
Għaliex din il-paġna ma tgħidx lili l-għażla?
Referenzi
Kull ċitazzjoni hawn taħt tgħaqqad mal-record oriġinali peer-reviewed fuq PubMed jew permezz ta' DOI. Xejn hawnhekk m'għandux ikun sostitut għal parir mediku.
-
Comparative effects of pharmacological interventions for the prevention of acute mountain sickness: A systematic review and Bayesian network meta-analysis Wang J, Lian N, Tang K, et al. · Travel medicine and infectious disease · 2025 · Meta-analysis DOIPubMed 40383249
-
Effect of nitrate supplementation on oxygen saturation levels for acute mountain sickness prevention: A systematic review and meta-analysis Nafi'an MRT, Sabirin RM, Wibowo RA, et al. · Nitric oxide : biology and chemistry · 2024 · Meta-analysis DOIPubMed 39002891
-
Ibuprofen versus acetazolamide for prevention of acute mountain sickness Schilling M, Irarrázaval S · Medwave · 2020 · Meta-analysis DOIPubMed 32604398
-
Acetazolamide for the treatment of acute mountain sickness Tapia L, Irarrázaval S · Medwave · 2019 · Meta-analysis DOIPubMed 31891352
-
Ginkgo biloba extract for prevention of acute mountain sickness: a systematic review and meta-analysis of randomised controlled trials Tsai TY, Wang SH, Lee YK, et al. · BMJ open · 2018 · Meta-analysis DOIPubMed 30121603Full text
-
Dexamethasone for the prevention of acute mountain sickness: systematic review and meta-analysis Tang E, Chen Y, Luo Y · International journal of cardiology · 2014 · Meta-analysis DOIPubMed 24679688
-
Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis Ritchie ND, Baggott AV, Andrew Todd WT · Journal of travel medicine · 2012 · Meta-analysis DOIPubMed 22943270
-
Altitude sickness Murdoch D · BMJ clinical evidence · 2010 · Systematic review PubMed 21718562Full text
-
Gut microbiota-targeted dietary supplementation with fermentable fibers and polyphenols prevents hypobaric hypoxia-induced increases in intestinal permeability Karl JP, Fagnant HS, Radcliffe PN, et al. · American journal of physiology. Regulatory, integrative and comparative physiology · 2025 · Randomised controlled trial DOIPubMed 40701649
-
Effects of acetazolamide combined with remote ischemic preconditioning on risk of acute mountain sickness: a randomized clinical trial Liu M, Jiao X, Li R, et al. · BMC medicine · 2024 · Randomised controlled trial DOIPubMed 38166913Full text
-
Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m Berger MM, Sareban M, Schiefer LM, et al. · Journal of applied physiology (Bethesda, Md. : 1985) · 2022 · Randomised controlled trial DOIPubMed 35511718
-
Acetazolamide does not alter endurance exercise performance at 3,500-m altitude Bradbury KE, Yurkevicius BR, Mitchell KM, et al. · Journal of applied physiology (Bethesda, Md. : 1985) · 2020 · Randomised controlled trial DOIPubMed 31804890
-
Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide Burns P, Lipman GS, Warner K, et al. · The American journal of medicine · 2019 · Randomised controlled trial DOIPubMed 30419226
-
Budesonide Versus Acetazolamide for Prevention of Acute Mountain Sickness Lipman GS, Pomeranz D, Burns P, et al. · The American journal of medicine · 2018 · Randomised controlled trial DOIPubMed 28668540
-
Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude Bailey DM, Davies B · High altitude medicine & biology · 2001 · Randomised controlled trial DOIPubMed 11252695
-
The incidence, importance, and prophylaxis of acute mountain sickness Hackett PH, Rennie D, Levine HD · Lancet (London, England) · 1976 · Randomised controlled trial DOIPubMed 62991
-
Altitude hypoxia and hypoxemia: pathogenesis and management Cai C, Ni G, Chen L, et al. · Signal transduction and targeted therapy · 2026 · Review DOIPubMed 41571626Full text
-
High Altitude Berger MM, Luks AM · Seminars in respiratory and critical care medicine · 2023 · Review DOIPubMed 37816346
-
Acute high-altitude sickness Luks AM, Swenson ER, Bärtsch P · European respiratory review : an official journal of the European Respiratory Society · 2017 · Review DOIPubMed 28143879Full text
-
Acute mountain sickness: pathophysiology, prevention, and treatment Imray C, Wright A, Subudhi A, et al. · Progress in cardiovascular diseases · 2010 · Review DOIPubMed 20417340
-
Wilderness Medical Society Clinical Practice Guidelines for the Prevention, Diagnosis, and Treatment of Acute Altitude Illness: 2024 Update Luks AM, Beidleman BA, Freer L, et al. · Wilderness & environmental medicine · 2024 · Journal article DOIPubMed 37833187